Carina Biotech and Sydney-based immuno-oncology company Glytherix are pleased to announce a co-development agreement that could result in a promising new CAR-T therapy that is effective in killing a range
Carina Biotech and biopharmaceutical company Biosceptre are pleased to announce they have signed an agreement that will see the advancement of a promising cancer immunotherapy. Biosceptre, developing targeted therapeutics and immune-oncology products,
Carina Biotech's board and management team are delighted to welcome Dr Deborah Rathjen as our new CEO. Deborah’s appointment coincides with Carina completing the first commercial transaction of its CAR-T
We are all very proud of our star researcher, Jade Foeng, who last night was presented with the inaugural 'Young Innovator' award at the 2019 Women in Innovation (Winnovation) awards
“The Dalai Lama feels that for Buddhism to grow that their understanding of the world must include all truths ... He saw the need for his most serious students to
Pulitzer Prize-winning author Siddhartha Mukherjee's article in the New Yorker provides a fascinating and easy to read history of CAR-T therapy and the incredible story of Emily Whitehead, the first
Science Daily reported on 11 April that investigators are using unusually small antibodies made naturally by alpacas, camels and llamas to target the environment around tumours in a new approach
Carina Biotech Managing Director Justin Coombs and the team were out at Mitre 10 in Glynde, SA, yesterday, for the first of many fundraising events as we attempt to raise
We're excited to announce that we'll be taking part in Shitbox Rally in October – driving a car worth $1000 or less from Melbourne to Townsville via Birdsville in Australia's largest
On 25 March the ABC reported that the Peter McCallum Cancer Centre in Melbourne would be the first home of newly approved CAR-T therapy treatment in Australia. Federal Health Minister Greg Hunt
